Sign up TODAY and try all premium features FREE for a Month!
Sign Up
Home Mf Research Aditya Birla Sun Life Pharma Healthcare Fund Regular Plan Growth
Aditya Birla Sun Life Mutual Fund

Aditya Birla Sun Life Pharma & Healthcare Fund - Regular Plan - Growth

Equity Equity Sectoral Thematic
Fund House : Aditya Birla Sun Life Mutual Fund
Overview
Returns
Portfolio
Analysis
Peer Comparison
Fund Family
Scheme Details
-
-
  • 1W
  • 2W
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • SI
NAV (as on 2025-06-19)
29.61 -0.94%
Fund Size (Total Assets)
-
Expense Ratio (Regular)
2.36%
Expense Ratio (Direct)
1.00%
SIP Returns
Period Invested for ₹1000 SIP Started on Investments Latest Value Abs. Returns
One Week 2025-06-12 ₹1,000.00 ₹973.69
-2.63 %
Two Week 2025-06-04 ₹1,000.00 ₹992.96
-0.70 %
One Month 2025-05-20 ₹1,000.00 ₹998.99
-0.10 %
Three Months 2025-03-21 ₹3,000.00 ₹2,989.91
-0.34 %
Six Months 2024-12-23 ₹6,000.00 ₹5,951.43
-0.81 %
One Year 2024-06-19 ₹12,000.00 ₹11,959.99
-0.33 %
Three Year 2022-06-20 ₹36,000.00 ₹48,693.05
35.26 %
Five Year 2020-06-22 ₹60,000.00 ₹91,140.89
51.90 %
Since Inception 2019-07-10 ₹73,000.00 ₹124,858.28
71.04 %
Portfolio Summary
Company Name Sector Sector Type Nav(in %)
Sun Pharmaceutical Industries Limited Pharmaceuticals & Biotechnology Equity 12.08
Cipla Limited Pharmaceuticals & Biotechnology Equity 7.69
Apollo Hospitals Enterprise Limited Healthcare Services Equity 7.18
Abbott India Limited Pharmaceuticals & Biotechnology Equity 6.09
Torrent Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 5.47
Lupin Limited Pharmaceuticals & Biotechnology Equity 4.72
Fortis Healthcare Limited Healthcare Services Equity 4.58
Ajanta Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 3.99
IPCA Laboratories Limited Pharmaceuticals & Biotechnology Equity 3.85
Aurobindo Pharma Limited Pharmaceuticals & Biotechnology Equity 3.82
Alkem Laboratories Limited Pharmaceuticals & Biotechnology Equity 3.12
Mankind Pharma Ltd Pharmaceuticals & Biotechnology Equity 3.05
ALEMBIC PHARMACEUTICALS LIMITED Pharmaceuticals & Biotechnology Equity 3.00
Emcure Pharmaceuticals Ltd Pharmaceuticals & Biotechnology Equity 2.90
J.B. Chemicals & Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 2.90
GlaxoSmithKline Pharmaceuticals Limited Pharmaceuticals & Biotechnology Equity 2.83
SAI Life Sciences Ltd Pharmaceuticals & Biotechnology Equity 2.37
Jupiter Life Line Hospitals Ltd Healthcare Services Equity 2.36
Divi's Laboratories Limited Pharmaceuticals & Biotechnology Equity 2.11
Medi Assist Healthcare Services Ltd Insurance Equity 1.59
Dr. Reddys Laboratories Limited Pharmaceuticals & Biotechnology Equity 1.52
Sanofi India Limited Pharmaceuticals & Biotechnology Equity 1.47
METROPOLIS HEALTHCARE LIMITED Healthcare Services Equity 1.39
Procter & Gamble Health Limited Pharmaceuticals & Biotechnology Equity 1.34
Suraksha Diagnostic Ltd Healthcare Services Equity 1.32
Akums Drugs & Pharmaceuticals Ltd Pharmaceuticals & Biotechnology Equity 1.21
SANOFI CONSUMER HEALTHCARE Pharmaceuticals & Biotechnology Equity 1.21
Max Healthcare Institute Limited Healthcare Services Equity 0.97
Vijaya Diagnostic Centre Limited Healthcare Services Equity 0.92
Vinati Organics Limited Chemicals & Petrochemicals Equity 0.88
Clearing Corporation of India Limited - Debt 2.17
Net Receivables / (Payables) - - -0.10
Risk Ratios
Standard Deviation
14.85
Beta
0.94
Sharpe Ratio
0.42
Lock In Period
-
Residual Maturity
-
Standard Deviation:
Standard deviation numbers measure the variability or volatility of a fund's returns over a specific time period (often 3 years).
  • Low standard deviation = Stable, predictable returns → Suitable for conservative investors seeking stability.
  • High standard deviation = High volatility, more risk → Be cautious, suitable for risk-tolerant investors who can handle fluctuations.
Beta:
Beta measures a fund's volatility about the market or a benchmark. A lower beta means the fund's performance is less sensitive to market movements, making it more predictable compared to the market.
  • Low beta = Less sensitive to market changes → Great for investors with less market exposure.
  • High beta = More sensitive to market changes → Better for aggressive investors who seek higher returns but can handle market risks.
Sharpe Ratio:
The Sharpe Ratio measures how much return a fund has made compared to the risk it carries. A higher Sharpe ratio indicates better returns relative to the risk taken, meaning the fund delivers more efficiently.
  • A higher Sharpe ratio indicates better risk-adjusted returns → Look for funds with higher ratios for better return efficiency.
  • Use it to compare different funds' efficiency in generating returns relative to the risk taken.
Lock-In Period:

India's "lock-in period" in mutual funds encourages long-term investment, particularly in tax-saving schemes preventing redemption or selling of units.

Lock-in times for various investment types

  • Most ELSS mutual fund holders hold for 3 years.
  • Tax savings FDs lock in for 5 years.
  • The lock-in period for 8% Government of India bond investment is 6 years.
  • ULIPs must be locked in for 5 years.
  • The average hedge fund holding period is 30-90 days.
  • The average PPF investor holds onto their money for 15 years.
Residual Maturity:

Residual maturity is the remaining time until a security reaches its maturity date. It is an important factor for investors to consider when evaluating the risk associated with an investment.

There are two different types of residual maturity.

  • Short-term residual maturity: This occurs when a security has less than a year left on its maturity.
  • Long-term residual maturity: This occurs when a security has more than a year left on its remaining maturity.
Scheme Details
  • Fund manager(s) : Mr. Dhaval Shah (), Mr. Dhaval Joshi (),
  • Expense ration regular : 2.36
  • Expense ration direct : 1.00
  • Launch date : -
  • Benchmark : -
  • Min SIP amount : -
  • Max SIP amount : -
  • Min investment amount (one time- first time) : ₹100.00
  • Type : equity
Exit load
1.00% if redeemed within 30 days, Nil thereafter

FAQs

Is a Mutual Fund with a Lower NAV Better?
What Are the Charges in Mutual Fund Investments?
What Are the Tax Benefits of Mutual Funds?
Is It a Good Time to Invest in Mutual Funds?
What Is the Difference Between Dividend and Growth Plans?
Should I Invest in Infrastructure Funds?
What Are Sector-Specific Funds/Schemes?
What Happens If I Miss an SIP Payment?
How Can I Compare Different Mutual Funds?